Matrix LIMS used by Liverpool GCPLab to track UK COVID-19 patient outcomes

Published: 3-May-2022

The GCPLab facility is providing the kits for taking samples from patients with COVID-19 in England and Wales

The Liverpool Good Clinical Practice Laboratory (GCPLab) Facility directed by Professor Bill Greenhalf, has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) running the Clinical Characterisation Protocol UK (CCP-UK) led by Professor Calum Semple in Liverpool, Dr Kenneth Baillie in Edinburgh and Professor Peter Openshaw at Imperial College London. The GCPLab facility is providing the kits for taking samples from patients with COVID-19 in England and Wales. The samples are then sent to leading UK laboratories for analysis of the virus from each patient and the biochemical and genetic features of the infected person.

These features of the virus and patient are then matched back to clinical data to determine why different patients have different outcomes and what treatments are working best for different groups of patients. The quick and efficient link back to the patient requires the precise workflows provided by the MATRIX LIMS system that has been used in Liverpool for many years. Sample collection in Scotland is being co-ordinated by the team of Dr Antonia Ho in Glasgow, originally using their own sample management system. To improve delivery and provide better standardisation the Glasgow team wanted to use the same MATRIX LIMS system as Liverpool, Autoscribe were asked to help and stepped in to provide licences for the MATRIX system, allowing remote access for Glasgow to the Liverpool database.

To read the full article, click here.

You may also like